Neuroprotective Effect and Mechanism of Thiazolidinedione on Dopaminergic Neurons In Vivo and In Vitro in Parkinson’s Disease

Figure 5

Effect of thiazolidinedione on PGC-1α, NRF1, and NRF2 protein levels. (a) The expression of PGC-1α, NRF1, and NRF2 in different groups; β-actin was used as the loading control. ((b)–(d)) PGC-1α, NRF1, and NRF2 protein levels. “aa” indicates , compared with control group; “b” indicates , compared with MPP⁺ group; “c” indicates , compared with 0.01 μmol/L 2,4-TZD group; “e” indicates , compared with 1 μmol/L 2,4-TZD group.

(a)

(b)

(c)

(d)